Atyr Pharma Inc (NASDAQ:ATYR) does about 1.49M shares in volume on a normal day but saw 2462162 shares change hands in the recent trading day. The company now has a market cap of 422.77M USD. Its current market price is $4.75, marking an increase of 6.26% compared to the previous close of $4.47. The 52 week high reached by this stock is $4.66 whilst the lowest price level in 52 weeks is $1.42.
The consensus objective for the share price is $18.55, suggesting that the stock has a potential upside of 74.39% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 18, 2025 when Leerink Partners initiated the stock to “Outperform” and issued a price target of $16. Wells Fargo initiated its price target at $17.
The current price level is 31.55%, 41.89%, and 53.88% away from its SMA20, SMA50, and SMA200 respectively, with the ATYR price moving below the 50-day SMA on current market day. Atyr Pharma Inc (ATYR) stock is up 26.67% over the week and 42.22% over the past month. Its price is 31.22% year-to-date and 182.74% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.18 and -0.66 for whole year. Expected sales for next quarter are $1.2M, which analysts say will come at $2M for the current fiscal year and next year at $27.67M.
To reach the target analysts have set, the stock logically needs to grow 74.39 percent from here.
Outstanding shares total 89.00M with insiders holding 2.23% of the shares and institutional holders owning 69.69% of the company’s common stock. The company has a return on investment of -73.10% and return on equity of -79.51%. The beta has a value of 0.88. Price to book ratio is 5.63.
